Dr. Furman Publishes Landmark Paper in NEJM: Pill Melts Away CLL

Richard Furman, MD

Dr. Richard Furman, Division of Hematology & Medical Oncology, and co-authors have published a landmark paper in the New England Journal of Medicine. Their results utilizing the drug, Idelalisib, in a randomized, double-blinded study (5 countries) suggests that a common form of leukemia may be treated without toxic chemotherapy.
Click for Weill Cornell Press Release

Top of page